Sabapathy, S., Neslusan, C., Yoong, K., Teschemaker, A., Johansen, P., & Willis, M. (2018). COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS SITAGLIPTIN WHEN ADDED TO METFORMIN AND SULFONYLUREA IN TYPE 2 DIABETES IN CANADA. Journal of Population Therapeutics and Clinical Pharmacology, 23(2). https://mail.jptcp.com/index.php/jptcp/article/view/206